Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding
- Conditions
- Abnormal Uterine Bleeding
- Interventions
- Device: Transvaginal sonography
- Registration Number
- NCT01786798
- Lead Sponsor
- Chulalongkorn University
- Brief Summary
The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 560
- Premenopausal women aged over than 35
- Abnormal uterine bleeding (menorrhagia/menometrorrhagia/metrorrhagia)
- Accept transvaginal examination (pelvic examination and ultrasound)
- Informed consent
- Severe uterine bleeding resulting in unstable vital signs
- Pregnancy
- Current medications: anticoagulants, selective serotonin reuptake inhibitor (SSRI), antipsychotics, corticosteroids, hormones, herbs
- Intrauterine device
- Genital tract pathologies: infection, submucous myoma distorting uterine cavity
- Systemic diseases that may cause coagulopathies: Thyroid disease, liver disease, pituitary/ hypothalamus diseases
- Not able to retrieve endometrial tissue
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Transvaginal sonography Transvaginal sonography -
- Primary Outcome Measures
Name Time Method The accuracy of endometrial thickness and endometrial pattern detected by transvaginal ultrasound in predicting endometrial hyperplasia and endometrial cancer. 14 months The endometrial thickness will be measured in millimeter, at the mid-sagittal plane of the uterus, near the uterine fundus. The measurement will be performed 3 times, from basal layer of the anterior to basal layer of the posterior wall of uterine cavity. The average value of 3 measurements will be used for statistical analysis.
The endometrial patterns are categorized into 3 groups:
1. Triple-layer appearance
2. Mixed echogenic pattern
3. Hyper-echogenic pattern
- Secondary Outcome Measures
Name Time Method To identify the cut-off points of endometrial thickness that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer. 14 months The results of endometrial thickness will be compared with the endometrial pathologies.The cut-off points of endometrial thickness, in millimeter, that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer will be analyzed using receiver operating characteristic (ROC) curve.
Trial Locations
- Locations (1)
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University
🇹đź‡Bangkok, Thailand